Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trellus HealthLSE:TRLS PB Ratio is 0.03 as of Sep. 02, 2026, which is 70% below its 10-year median of 0.10. The stock has 2 warning signs investors should review. Among 614 Healthcare Providers & Services companies, Trellus Health ranks better than 99.67% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-09-02), Trellus Health's share price is £0.0012. Trellus Health's Book Value per Share for the quarter that ended in Jun. 2025 was £0.04. Hence, Trellus Health's PB Ratio of today is 0.03.
The historical rank and industry rank for Trellus Health's PB Ratio or its related term are showing as below:
LSE:TRLS'
s PB Ratio Range Over the Past 10 Years
Min: 0.02 Med: 0.1 Max: 0.45
Current: 0.03
During the past 5 years, Trellus Health's highest PB Ratio was 0.45. The lowest was 0.02. And the median was 0.10.
LSE:TRLS's PB Ratio is ranked better than 99.67% of 614
companies
in the Healthcare Providers & Services industry
Industry Median: 1.96
vs LSE:TRLS: 0.03
During the past 12 months, Trellus Health's average Book Value Per Share Growth Rate was -47.40% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -29.30% per year.
During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Trellus Health was 68.10% per year. The lowest was -29.30% per year. And the median was 19.40% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Trellus Health PB Ratio Related Terms
Trellus Health PB Ratio Historical Data
* Premium members only.
The historical data trend for Trellus Health's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Trellus Health's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trellus Health PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Trellus Health's PB Ratio distribution charts can be found below:
* The bar in red indicates where Trellus Health's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Trellus Health's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Trellus Health (LSE:TRLS) has a PB Ratio of 0.03 as of Sep. 02, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Trellus Health and its competitors. This is 70% below median its historical median of 0.10. Over the past decade, Trellus Health's PB Ratio has ranged from 0.02 to 0.45. According to the industry distribution chart, Trellus Health ranks #2 out of 614 companies in the Healthcare Providers & Services industry, placing it in the top 0.3%.
Is Trellus Health's PB Ratio too high?
Trellus Health's current PB Ratio of 0.03 is 70% below median its 10-year median of 0.10. Over the past 10 years, this metric has ranged from a low of 0.02 to a high of 0.45. The Healthcare Providers & Services industry median PB Ratio is 1.96. Trellus Health's value of 0.03 is 98.5% below this industry median. Based on the distribution chart, Trellus Health ranks #2 out of 614 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers.
How does Trellus Health's PB Ratio compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Trellus Health ranks #2 out of 614 companies for PB Ratio. This places Trellus Health in the top 0% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.96. Trellus Health's value of 0.03 is 98.5% below this benchmark. Historically, Trellus Health's own PB Ratio has ranged from 0.02 to 0.45 over the past decade. While the company's 10-year median is 0.10 vs. the industry median of 1.96, Trellus Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 1.96, based on 614 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trellus Health's current PB Ratio of 0.03 is 98.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Trellus Health and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trellus Health's current PB Ratio is 0.03, which is 70% below median its own 10-year median of 0.10. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trellus Health stock overvalued right now?
Trellus Health (LSE:TRLS) has a current PB Ratio of 0.03. The current PB Ratio is 0.03, which is 70% below median its 10-year median of 0.10 and 98.5% below the Healthcare Providers & Services industry median of 1.96. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Trellus Health (LSE:TRLS), the current PB Ratio is 0.03 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Trellus Health PLC is commercializing the provision of digital chronic condition management solutions for employers and health plans that utilize the scientifically validated GRITT resilience-based methodology and a proprietary HIPAA-compliant technology platform called TrellusElevate to coordinate and deliver personalized care. The company is initially focused on Inflammatory Bowel Diseases, which include the chronic incurable conditions of Crohn's Disease and ulcerative colitis but considers its approach to have potential utility and demand across many chronic conditions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:TRLS has been successfully added to your 
